Refreshing to see pics of clinicians celebrating trials *without* industry adverts. Congrats on doing such great science 👇🏻

Best place for Cath lab based research in the UK. Amazing Cath lab team, research and management support 💛 MSE Research Team 💙 Mid and South Essex Integrated Care System EssexCTC Essex Heart Fund Mid and South Essex NHS Foundation Trust

No rest for the ORBITA team! Recruitment is going strong for ORBITA-FIRE which is being led by Fiyyaz Ahmed-Jushuf. Thank you to Klio Konstantinou and the Essex CTC a fantastic case this week
@Drkeeble
@dizzledavies73

Q: Does blinding matter in RCTs of surgical procedures? A: Depends on the endpoint JAMA Surgery

We compared placebo-controlled and open-label surgical trials to identify when the placebo effect is most powerful Rasha Al-Lamee Katie Thomas NHLI

jamanetwork.com/journals/jamas…

Goodbye #ACC from the ORBITA team. Thank you for featuring our work and see you again next year! Florentina Simader Shayna Chotai Michael Foley Christopher Rajkumar Fiyyaz Ahmed-Jushuf Matthew Shun-Shin

Couldn’t be prouder of Michael Foley and the ORBITA team today. What are the chances that ORBITA-COSMIC would be published on the same day as a solar eclipse?!

PCRonline 🫀 coverage of #ORBITA - COSMIC - Impact of CSR on pts with refractory angina

🎥 pcronline.com/News/Whats-new…

The Lancet Simpub: thelancet.com/journals/lance…

Congrats Rasha Al-Lamee Michael Foley & thanks for the insights!

Christopher Rajkumar Fiyyaz Ahmed-Jushuf Matthew Shun-Shin Florentina Simader #ACC2024

Amazing to see a brilliant friend and colleague Michael Foley present the #ORBITA -COSMIC trial of the coronary sinus reducer with simultaneous publication in The Lancet Rasha Al-Lamee NHLI Imperial NHS 💙 #ACC2024

thelancet.com/journals/lance…

Here we go again! Want to see if the coronary sinus reducer works in refractory angina? Watch Michael Foley present the results of the ORBITA-COSMIC in the main arena at #ACC this Monday #ORBITA Fiyyaz Ahmed-Jushuf Matthew Shun-Shin Shayna Chotai Christopher Rajkumar Florentina Simader

Incredibly proud to celebrate Rasha Al-Lamee being awarded the Global CV Future Leader Award 2024 #GCVAwards . An exceptional mentor to us, who has also built a strong team of young researchers at Imperial College Matthew Shun-Shin Christopher Rajkumar Michael Foley Florentina Simader Shayna Chotai

Great stuff from Peter Haworth and colleagues in Portsmouth recruiting their first patient to ORBITA-FIRE Rasha Al-Lamee

Very happy to have enrolled our first patient into the brilliant ORBITA-FIRE study, after ORBITA 2. Amazing help from the wonderful Imperial team. Really great to get stuck into high quality coronary physiology assessment. Fiyyaz Ahmed-Jushuf Rasha Al-Lamee Brijesh Anantharam #ORBITA -FIRE

ahajournals.org/doi/10.1161/CI…

Read our paper here Rasha Al-Lamee Christopher Rajkumar Florentina Simader Fiyyaz Ahmed-Jushuf

Delighted to see our ORBITA-COSMIC design paper published in Eurointervention. Now for the results! My thanks as ever to my supervisors and the incredible ORBITA team Rasha Al-Lamee Matthew Shun-Shin Christopher Rajkumar Fiyyaz Ahmed-Jushuf Florentina Simader Graham Cole Prof Darrel Francis ☺ Mk CardioFellows Great Again

My TCTMD video around ORBITA-2 with Rasha Al-Lamee and Christopher Rajkumar : 📽️tctmd.com/videos/beyond-…
💡 how representative are trial participants?
💡Does this trial mean we can offer pci upfront of anti- anginal therapy?
💡 should we change guidelines?

#AHA2023 Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

There is an unsung hero in the ORBITA family and we don’t do forgotten heroes. Matthew Shun-Shin is the cleverest man I know and responsible for all the statistics and beautiful figures in ORBITA-2 (with a little help from my RAL chart). Give this man a round of applause!

Excellent deep dive with #orbita2 happening now #AHA23 with Christopher Rajkumar Rasha Al-Lamee Dipti Itchhaporia, M.D., MACC , FAHA, FESC.
Remember, all 301 angiograms are published in the supplementary appendix (as done in the first ORBITA so you can see for yourself). Median FFR=0.63, iFR=0.78 at randomisation

This is the principal question of the ORBITA-STAR trial, coming in the next year Rasha Al-Lamee NHLI

All the first 5 authors of #orbita2 are UK cardiology fellows which could only have been possible under the exceptional mentorship, supervision and drive of Rasha Al-Lamee. I feel deeply humbled and proud to have been part of this incredible team!
#AHA23 BCIS
BJCA 📊 European Society of Cardiology

Gareth and I were delighted to receive the award on behalf of the amazing work that Sudden Cardiac Arrest UK does to support survivors, co-survivors and rescuers post OHCA in the uk and beyond @drKeeble EssexCTC Essex Heart Fund ARU MTRC 💛 MSE Research Team 💙 - huge honour